TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1 July 15, 1983